Monomer Bio
PrivateLast Round
Seed
Jan 31, 2024
Total Funding Raised
$5.6M
Momentum Score
25 /100
Company Overview
Monomer Bio is a healthcare technology company that provides an integrated lab automation and analytics software platform built for cell biology workflows.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Workflow Automation, Drug Discovery, ML Platforms, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Monomer Bio Comps
Public and private peers based on sector, stage, and business model.
Monomer Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 31, 2024 |
Monomer Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Notley | Seed |
| Talis Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors grew 135% MoM, reaching 2.8K.
- Apr 28, 2025
Added The Organoid Company, a biotechnology startup, as a customer.
Monomer Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Monomer Bio's valuation, stock price, and market status.
